Test of bacteria toxin delivery system could pave way for new antibiotic drugs

June 16, 2008
Test of bacteria toxin delivery system could pave way for new antibiotic drugs
Scanning electron microscopy image of bacteria (the cylindrical objects) attached to host cells. These bacteria are in the process of injecting the host cells with the toxins. Credit: Hebrew University illustration

Researchers at the Hebrew University of Jerusalem have achieved a breakthrough in monitoring the toxin-delivery system of highly pathogenic bacteria – an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs.

Most bacteria are harmless and do not cause infections. Some, however, are pathogenic and are equipped with special accessories that are used to deliver toxins (also termed "effectors") into the cells of the infected person.

Numerous bacteria that cause disease, ranging from food poisoning to life threatening infection, employ a syringe-like nano-organelle (a specialized part of a cell having a specific function) that is used to inject toxic effectors into attacked host cells. This process is termed a type III secretion system (TTSS). Among these pathogens are Salmonella; the cause of typhoid fever, Yersinia; and enteropathogenic (intestinal) E. coli, which is responsible for the death of up to one million infants per year, mostly in developing countries.

The bacterial syringe employed by these bacteria is an excellent potential target for drugs (not yet available) to combat these diseases. In order to develop such drugs, however, a better understanding of the syringe functions is needed, requiring development of better methods for measuring the syringe activity.

The Hebrew University researchers – Ilan Rosenshine, the Etta Rosensohn Professor of Bacteriology at the Hebrew University Faculty of Medicine, and his associates -- Erez Mills, Kobi Baruch, Xavier Charpentier and Simi Kobi -- have designed a new, real-time test that allows monitoring the syringe activity. Using this test, they have discovered new properties of this system, which might be used to develop drugs that will inhibit the syringe activity and thereby prevent disease and infection by these dangerous pathogens

Their achievement was described in a recent article in the journal Cell Host & Microbe.

Source: The Hebrew University of Jerusalem

Explore further: Snake venom helps hydrogels stop the bleeding

Related Stories

New device promises safer way to deliver powerful drugs

April 6, 2011

A new drug delivery device designed and constructed by Jie Chen, Thomas Cesario and Peter Rentzepis promises to unlock the potential of photosensitive chemicals to kill drug-resistant infections and perhaps cancer tumors ...

Revealing the weapons by which bacteria fight each other

April 4, 2013

A new study which was performed jointly at Umea University and the University of Washington in Seattle, USA, discovered that bacteria can degrade the cell membrane of bacterial competitors with enzymes that do not harm their ...

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.